Manulife US REIT - RHB Research 2025-05-27: Making a Slow Recovery

• Manulife US REIT (SGX:BTOU)’s disposal of its Peachtree asset – done at a deep discount to its 2024 valuation – was a painful move, but a necessary step towards its long-term recovery.
• - Read this at SGinvestors.io -

Peachtree sold for US$133.8m

• The sale of Peachtree for US$133.8m, excludes seller’s credit of US$12.6m for the outstanding tenant improvement allowances, capex costs, free rent, and lease commisions. The sale price represents a 19% discount to the asset’s end-Dec 2024 valuation, but in line with the latest Apr 2025 valuation.
• - Read this at SGinvestors.io -
• The sale will have a positive impact on leverage, lowering it to 56.3% from 59.4% (1Q), while weighted average interest cost would drop by ~40bps to 3.94%.

Exploring the sale of another tranche-1 asset that is currently in progress.

• Read more at SGinvestors.io.

Above is an excerpt from a report by RHB Securities Research.
Clients of RHB may be the first to access the full PDF report @ https://www.rhbtradesmart.com/.

Read also RHB's most recent report:
2026-03-19 Manulife US REIT - In Transition.

Price targets by other brokers at Manulife US REIT Target Prices.

Listing of research reports at Manulife US REIT Analyst Reports.

Relevant links:
Manulife US REIT Share Price History,
Manulife US REIT Announcements,
Manulife US REIT Dividend Payout Dates & Corporate Actions,
Manulife US REIT News